Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04267237
Brief Title: A Study of the Efficacy and Safety of RO7198457 in Combination With Atezolizumab Versus Atezolizumab Alone Following Adjuvant Platinum-Doublet Chemotherapy in Participants Who Are ctDNA Positive After Surgical Resection of Stage II-III Non-Small Cell Lung Cancer

First Submitted : February 7, 2020
First Submitted that Met QC Criteria : February 11, 2020
First Posted : February 12, 2020

Last Update Submitted that Met QC Criteria : February 1, 2021
Last Update Posted : February 4, 2021